Biocon Ltd News Today

YESINTEK targets specific proteins that trigger inflammation, which presents new therapeutic options in the chronic management of autoimmune diseases.

Ethiopia, with a prevalence of 2-3%, is one of the top four nations in Sub-Saharan Africa for adult diabetics.

The combined cGMP inspection and pre-licensing inspection (PLI), which took place between July 15 and July 26, 2024, is the subject of this update.

Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.

The company's operating revenue climbed 3.7% to Rs 3,590.4 crore from Rs 3,462 crore in Q2 of FY24.

Here are some of the stocks that may see significant price movement today: Larsen & Toubro, Tata Power, Biocon, etc.

The inspection, which took place between September 23 and September 27, 2024, concluded with four observations from the regulatory organisation.

Here are some of the stocks that may see significant price movement today: Nuvama Wealth, RITES, Torrent Pharmaceuticals, etc.

The partnership focuses on commercializing GLP-1 (glucagon-like peptide-1) products for diabetes treatment and chronic weight management in the Middle East.

LIC's shareholding in Biocon has grown from 5,98,14,429 shares to 6,03,14,429 shares.